Novan

company

About

Novan is a clinical-stage drug development company developing deliverable nitric oxide.

  • 101 - 250

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$50M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2008
Number Of Employee
101 - 250
Operating Status
Active

Novan develops products that tap the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. They use its proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs.

The company is committed to using the power of the human body to create safe and effective treatments. They complement their internal scientific talent with strategic partners around the globe to enable Novan to harness the power of nitric oxide and develop technologies that will help address currently untreated and under-treated medical conditions.

It was incorporated in 2008 and is based in Morrisville, North Carolina.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Novan has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Mar 30, 2015 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 30, 2015 Private Equity(PE) $50M 1 Malin Corporation Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Novan has made 1 investments. Their most recent investment was on Dec 28, 2021, when Ready Player Me raised $13M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 28, 2021 Ready Player Me
Series A $13M 3D Technology

Investors

Number of Lead Investors
Number of Investors
1
1
Novan is funded by 1 investors. Malin Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
Malin Corporation Yes Private Equity(PE)